ML25044A009
| ML25044A009 | |
| Person / Time | |
|---|---|
| Issue date: | 02/19/2025 |
| From: | Christopher Regan Office of Nuclear Material Safety and Safeguards |
| To: | Kohl P - No Known Affiliation |
| References | |
| NRC-2022-0218, RIN 3150-AK91 | |
| Download: ML25044A009 (1) | |
Text
Pam Kohl Pamkohl52@gmail.com
Dear Pam Kohl:
Thank you for your e-mail dated January 26, 2025, regarding your concerns over NRCs proposed rule and associated guidance on Reporting Nuclear Medicine Injection Extravasations as Medical Events under SECY-24-0067. The draft proposed rule and associated guidance are currently with the Commission for review and approval.
We will place your letter on the docket. Your concerns will be considered as we continue the rulemaking process, and, if the proposed rule is approved by the Commission, we strongly encourage you to submit your concerns in a comment on the proposed rule. Specific information about the rulemaking can be found at https://www.nrc.gov/reading-rm/doc-collections/rulemaking-ruleforum/active/ruledetails.html?id=2180 and at https://www.regulations.gov under Docket ID NRC-2022-0218. We look forward to your continuing participation and engagement in our rulemaking process.
If you have any questions or need additional information, please contact me at Christopher.Regan@nrc.gov or Irene Wu at Irene.Wu@nrc.gov.
Sincerely, Christopher Regan, Director Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards February 19, 2025 Ralph, Melissa signing on behalf of Regan, Christopher on 02/19/25
ML25044A009 OFFICE NMSS/REFS/
MRPB NMSS/REFS/
MRPB NMSS/REFS OGC NMSS/REFS NAME IWu ACarrera MRalph for CRegan TJones CRegan DATE 2/13/2025 2/13/2025 2/18/2025 2/18/25 2/19/2025